A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Metformin/rosuvastatin (Primary)
- Indications Diabetes mellitus; Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 27 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 27 Jul 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2017.
- 07 Dec 2016 New trial record